Gibson Capital LLC Buys Shares of 1,290 Agilent Technologies, Inc. (NYSE:A)

Gibson Capital LLC purchased a new stake in shares of Agilent Technologies, Inc. (NYSE:A) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 1,290 shares of the medical research company’s stock, valued at approximately $188,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Ballentine Partners LLC increased its stake in Agilent Technologies by 2.5% during the 1st quarter. Ballentine Partners LLC now owns 2,963 shares of the medical research company’s stock valued at $431,000 after buying an additional 73 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its holdings in Agilent Technologies by 3.2% during the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 2,421 shares of the medical research company’s stock worth $337,000 after purchasing an additional 75 shares in the last quarter. Carmel Capital Partners LLC lifted its position in Agilent Technologies by 1.2% in the fourth quarter. Carmel Capital Partners LLC now owns 6,709 shares of the medical research company’s stock worth $933,000 after purchasing an additional 78 shares during the period. Monumental Financial Group Inc. boosted its stake in Agilent Technologies by 0.9% during the 4th quarter. Monumental Financial Group Inc. now owns 9,493 shares of the medical research company’s stock valued at $1,320,000 after purchasing an additional 89 shares in the last quarter. Finally, Kepos Capital LP increased its position in shares of Agilent Technologies by 3.5% during the 3rd quarter. Kepos Capital LP now owns 2,775 shares of the medical research company’s stock valued at $310,000 after purchasing an additional 93 shares during the period.

Analyst Ratings Changes

A has been the subject of several research analyst reports. JPMorgan Chase & Co. cut their price objective on Agilent Technologies from $165.00 to $155.00 and set an “overweight” rating for the company in a report on Thursday, May 30th. Oppenheimer lifted their price objective on shares of Agilent Technologies from $67.00 to $90.00 and gave the stock an “outperform” rating in a research note on Tuesday, March 26th. TD Cowen cut their target price on shares of Agilent Technologies from $163.00 to $153.00 and set a “buy” rating for the company in a research note on Thursday, May 30th. Barclays decreased their price target on shares of Agilent Technologies from $135.00 to $125.00 and set an “underweight” rating on the stock in a research report on Friday, May 31st. Finally, Wolfe Research downgraded Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research report on Thursday. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, Agilent Technologies has a consensus rating of “Hold” and a consensus target price of $136.88.

Agilent Technologies Stock Down 0.9 %

NYSE A traded down $1.17 during trading on Friday, reaching $129.63. 9,817,612 shares of the company’s stock were exchanged, compared to its average volume of 2,591,764. The company has a current ratio of 2.15, a quick ratio of 1.64 and a debt-to-equity ratio of 0.34. Agilent Technologies, Inc. has a fifty-two week low of $96.80 and a fifty-two week high of $155.35. The company’s fifty day simple moving average is $139.56 and its 200-day simple moving average is $138.47. The firm has a market capitalization of $37.82 billion, a PE ratio of 30.65, a P/E/G ratio of 4.40 and a beta of 1.07.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, May 29th. The medical research company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.19 by $0.03. The business had revenue of $1.57 billion during the quarter, compared to analyst estimates of $1.58 billion. Agilent Technologies had a net margin of 18.84% and a return on equity of 26.25%. The firm’s revenue was down 8.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.27 earnings per share. Sell-side analysts predict that Agilent Technologies, Inc. will post 5.25 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 24th. Stockholders of record on Tuesday, July 2nd will be paid a $0.236 dividend. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.73%. The ex-dividend date of this dividend is Tuesday, July 2nd. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.22%.

Insider Buying and Selling

In other news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $130.00, for a total transaction of $254,540.00. Following the completion of the sale, the chief executive officer now directly owns 25,185 shares in the company, valued at approximately $3,274,050. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In related news, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $130.00, for a total value of $254,540.00. Following the completion of the sale, the chief executive officer now directly owns 25,185 shares in the company, valued at $3,274,050. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Dominique Grau sold 15,000 shares of the business’s stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $133.28, for a total value of $1,999,200.00. Following the transaction, the senior vice president now directly owns 49,486 shares of the company’s stock, valued at approximately $6,595,494.08. The disclosure for this sale can be found here.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.